Braxia Scientific Corp. BRAXF
Set alert
At close · Oct 30
- YTD
- 0.00%
- 1 year
- -92.19%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 28.33K
- Vol
- 480.00K
- Avg vol
- 39
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
News
1 year ago newsfilecorp.com
Braxia Scientific Update
Toronto, Ontario--(Newsfile Corp. - February 19, 2025) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), provides an update on various…
1 year ago newsfilecorp.com
Braxia Scientific Announces Change in Directors and CEO
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company") announced that Jerry Habuda has resigned as a…
2 years ago newsfilecorp.com
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders
Sale of Company's Assets Approved Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), is pleased to…
2 years ago newsfilecorp.com
Braxia Announces Annual General and Special Meeting
Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company") announced today that an annual…
2 years ago newsfilecorp.com
Braxia Scientific Announces Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - August 5, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FWB: 4960), ("Braxia Scientific", or the "Company"), today announced that the Ontario…
2 years ago newsfilecorp.com
Braxia Scientific Provides Update on Application for Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - July 25, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), today announced further to its press…
2 years ago newsfilecorp.com
Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - July 15, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), today announced that it has made an…
2 years ago newsfilecorp.com
Braxia Scientific Reports Q3 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - February 29, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research company with…
2 years ago newsfilecorp.com
Braxia Scientific Reports Mandatory Conversion of Debentures
Toronto, Ontario--(Newsfile Corp. - January 15, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research company with…
2 years ago newsfilecorp.com
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - November 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company with…
3 years ago newsfilecorp.com
Braxia Scientific Reports Q1 Fiscal 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - August 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research and telemedicine…
3 years ago newsfilecorp.com
Braxia Scientific Reports Fiscal 2023 Financial Results
Braxia Health ketamine treatments up 26% YoY in 2023 and revenue up 27% YoY Company completes dosing of final participant in Phase 2, multi-dose Psilocybin trial, results expected to be published…
3 years ago proactiveinvestors.com
Braxia Scientific reports significant increase in treatment volumes across its clinics
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has reported a significant increase in treatment volumes across its clinics, which rose by 26.2% in fiscal 2023 to 3,516, compared to 2,785 treatments in…
3 years ago proactiveinvestors.com
Braxia Scientific announces termination of Irwin Naturals merger LOI; retains strategic clinical assets
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) announced that Irwin Naturals Inc has terminated the non-binding amended and restated letter of intent (LOI) for a business combination between Irwin and…
3 years ago proactiveinvestors.com
Braxia Scientific reports 50.5% increase in 3Q revenue; updates on acquisition by Irwin Naturals
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has reported third-quarter results that show a sharp rise in revenue as the company increased its in-clinic ketamine treatments and continued to expand…
3 years ago proactiveinvestors.com
Braxia Scientific closes first tranche of its non-brokered offering for aggregate proceeds of $751,218.83
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said it has closed the first tranche of its previously announced non-brokered offering resulting in the issuance of 13,658,524 units of the company at a…
3 years ago proactiveinvestors.com
Braxia Scientific announces up to $1.5M offering and concurrent private placement
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has announced an offering of up to 27,272,727 units of the company at a price of $0.055 each for aggregate proceeds of up to $1.5 million pursuant to the…
3 years ago proactiveinvestors.com
Irwin Naturals announces LOI to acquire Braxia Scientific to create new market leader
Irwin Naturals Inc. (CSE:IWIN) said it has entered into a non-binding amended and restated Letter of Intent (LOI) for a business combination with Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) in a…
3 years ago proactiveinvestors.ca
Irwin Naturals an Braxia Scientific partner to accelerate in-human development of new therapies for mental health
Irwin Naturals Inc. (CSE:IWIN) and Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) have signed a Letter of Intent (LOI) entering into a partnership to launch Clinical Research Services across Irwin's…
3 years ago proactiveinvestors.com
Braxia Scientific sees Q2 revenue increase, with in-clinic treatment up 34.5%
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has announced an increase in revenues for its second quarter and the first half ended September 30, 2022, with in-clinic treatment rising by 34.5% as it…